What is the best malaria chemoprophylaxis regimen for a 27-year-old male soldier with well-controlled depression deploying to the southern border of Saudi Arabia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Best Malaria Chemoprophylaxis for This Soldier: Atovaquone-Proguanil or Doxycycline

For this 27-year-old soldier with controlled depression deploying to southern Saudi Arabia, either atovaquone-proguanil or doxycycline is the best choice, with mefloquine absolutely contraindicated due to his psychiatric history.

Critical Contraindication: Mefloquine and Depression

The most important consideration here is that mefloquine should NOT be given to those with a history of convulsions, epilepsy, or serious psychiatric disorder 1. The guidelines explicitly state that mefloquine causes neuropsychiatric side effects including anxiety, depression, sleep disturbances, nightmares, hallucinations, and overt psychotic attacks, occurring in 70% of cases within the first three doses 1. Even though this patient's depression is "controlled," the risk of precipitating a severe psychiatric episode in a military deployment setting is unacceptable.

Recommended Options

Primary Recommendation: Atovaquone-Proguanil

  • Excellent safety profile with no psychiatric contraindications
  • Daily dosing regimen
  • Well-tolerated with minimal side effects
  • Appropriate for chloroquine-resistant areas (if present in southern Saudi Arabia)

Alternative: Doxycycline

  • Second-line option for those unable to take other agents 1
  • Daily dosing
  • Key caveat: Photosensitization risk - "sometimes severe and prolonged. Excessive exposure to sun should be avoided" 1. This is particularly relevant for a soldier at the southern Saudi border with significant sun exposure
  • Military data shows doxycycline users are significantly more likely to stop due to adverse events 2

Not Recommended: Chloroquine Alone

While chloroquine may be appropriate if southern Saudi Arabia has chloroquine-sensitive malaria only, this requires specific regional resistance data. The guidelines note chloroquine efficacy is "limited in sub-Saharan Africa and low in South East Asia" 1, and without confirmed chloroquine sensitivity in this specific region, it's not the optimal choice.

Compliance Considerations

Weekly regimens show significantly better compliance than daily regimens 2, which would favor mefloquine under normal circumstances. However, the psychiatric contraindication overrides this advantage. Between the two daily options:

  • Atovaquone-proguanil has better tolerability
  • Doxycycline has higher discontinuation rates due to adverse events 2

Practical Algorithm

  1. Confirm regional resistance patterns for southern Saudi Arabia
  2. If chloroquine-resistant area exists: Choose atovaquone-proguanil as first-line
  3. If cost is prohibitive or atovaquone-proguanil unavailable: Use doxycycline with strict sun protection counseling
  4. If confirmed chloroquine-sensitive area only: Chloroquine 300mg base weekly is acceptable
  5. Never use mefloquine in this patient

Military Context

Military travelers show worse compliance overall 2, making tolerability even more critical. The Italian Army guidelines recommend mefloquine as first-line for chloroquine-resistant areas 3, but this patient's psychiatric history makes him an exception to standard military protocols.

Start chemoprophylaxis one week before departure to establish the habit and identify any adverse effects before deployment 1. Continue for four weeks after return 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.